10 years of researching nk-cells for mm treatment
Published 6 years ago • 1.6K plays • Length 2:29Download video MP4
Download video MP3
Similar videos
-
3:15
promising results for mm treatment with natural killer cells
-
2:01
cellular therapy: nk-cells as a model
-
5:20
immuno-oncology agents for mm: checkpoint inhibitors and nk-cells
-
0:48
advantages of primary nk cells for the treatment of patients with hematological malignancies
-
1:57
perspectives on allogeneic nk cell-based immunotherapy
-
1:00
exploring the potential of nk cells in mitigating relapse after allogeneic transplantation
-
2:41
myeloma research: the next 10 years
-
2:08
advances in gene engineering technologies for nk cell-based immunotherapy
-
0:44
nk cells vs t-cells
-
1:19
gene editing of nkg2a to enhance nk cell cytotoxicity against multiple myeloma cells
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
1:11
the future of cord blood-derived nk cells and how their persistence can be improved
-
1:19
car-t vs car-nk for myeloma
-
18:39
immunotherapy in myeloma: current strategies and future perspectives
-
5:02
innate cell engager (ice®) afm13 combined with cord blood-derived nk cells for r/r cd30 lymphoma
-
5:23
karmma-2 cohort 2b update: ide-cel for transplant-ineligible patients with high-risk myeloma
-
1:44
pnk-007: allogeneic nk-cell product post-asct in mm
-
1:03
the growing importance of single-cell rna sequencing in hematology